Dr. Reddy's Laboratories Ltd gets 3 observations from USFDA for R&D Centre

The United States Food & Drug Administration (USFDA) today completed a GMP and Pre-Approval Inspection (PAI) at our R&D centre (Integrated Product Development Organisation or IPDO) in Bachupally, Hyderabad. The inspection was conducted from December 4, 2023 to December 8, 2023. The company has been issued a Form 483 with three observations, which we will address within the stipulated timeline.

Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 5763.50 as compared to the previous close of Rs. 5784.05. The total number of shares traded during the day was 6492 in over 1084 trades.

The stock hit an intraday high of Rs. 5781.60 and intraday low of 5712.00. The net turnover during the day was Rs. 37342211.00.

Source : Equity Bulls

Keywords

DrReddysLaboratories INE089A01023 USFDA Inspection RandDCentre Form483 3Observations